Aspirin for the Treatment of Nonalcoholic Fatty Liver Disease

Clinical trial NCT04031729 · COMPLETED

Trial details

NCT number: NCT04031729
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Nonalcoholic Fatty Liver Nonalcoholic Steatohepatitis

Start date: 2019-09-12
Primary completion: 2023-02-23
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.